Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
종목 코드 AKYA
회사 이름Akoya Biosciences Inc
상장일Apr 16, 2021
CEOMr. Brian Mckelligon
직원 수205
유형Ordinary Share
회계 연도 종료Apr 16
주소100 Campus Drive
도시MARLBOROUGH
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호01762
전화18558968401
웹사이트https://www.akoyabio.com/
종목 코드 AKYA
상장일Apr 16, 2021
CEOMr. Brian Mckelligon
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음